Ricevi le ultime notizie sulle azioni SenesTech con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di SNES

Ultime notizie per

SENESTECH INC

SenesTech

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

SenesTech Inc

Commodities

Press Releases

SenesTech Announces Bradley Caldwell, Inc. as New U.S. Distributor for Evolve Rodent Fertility Control Products

Small Cap

Baltimore Expands Use of Evolve™ Rodent Birth Control Following Successful Pilot

SenesTech and Irvine Campus Housing Authority Conclude Successful Field Trial of Evolve™ Rat Birth Control at UC Irvine

SenesTech's Evolve™ Rodent Birth Control Proven in Urban Rodent Hotspots from Hong Kong to San Francisco

Offerings

SenesTech Announces Warrant Exercise for $4.4 Million in Gross Proceeds

SenesTech Announces Closing of Warrant Exercise for $4.4 Million in Gross Proceeds

SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

SenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds

SenesTech Announces Closing of Warrant Exercise for $6.3 Million in Gross Proceeds

Earnings

SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

SNES

AN2 Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Aytu BioPharma

CalciMedica

Cingulate

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Cocrystal Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Gelteq

Hoth Therapeutics

IGC Pharma

Iterum Therapeutics

Incannex Healthcare

Lexaria Bioscience

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

Pulmatrix

PolyPid

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

SCYNEXIS

HC Wainwright & Co.

Comments

SenesTech Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO